Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2002 Feb 19;994:2374-9. doi: 10.1073/pnas.022285899.
Show Gene links
Show Anatomy links
Attenuation of thermal nociception and hyperalgesia by VR1 blockers.
García-Martinez C, Humet M, Planells-Cases R, Gomis A, Caprini M, Viana F, De La Pena E, Sanchez-Baeza F, Carbonell T, De Felipe C, Pérez-Paya E, Belmonte C, Messeguer A, Ferrer-Montiel A.
???displayArticle.abstract???
Vanilloid receptor subunit 1 (VR1) appears to play a critical role in the transduction of noxious chemical and thermal stimuli by sensory nerve endings in peripheral tissues. Thus, VR1 antagonists are useful compounds to unravel the contribution of this receptor to pain perception, as well as to induce analgesia. We have used a combinatorial approach to identify new, nonpeptidic channel blockers of VR1. Screening of a library of trimers of N-alkylglycines resulted in the identification of two molecules referred to as DD161515 [N-[2-(2-(N-methylpyrrolidinyl)ethyl]glycyl]-[N-[2,4-dichlorophenethyl]glycyl]-N-(2,4-dichlorophenethyl)glycinamide] and DD191515 [[N-[3-(N,N-diethylamino)propyl]glycyl]-[N-[2,4-dichlorophenethyl]glycyl]-N-(2,4-dichlorophenethyl)glycinamide] that selectively block VR1 channel activity with micromolar efficacy, rivaling that characteristic of vanilloid-related inhibitors. These compounds appear to be noncompetitive VR1 antagonists that recognize a receptor site distinct from that of capsaicin. Intraperitoneal administration of both trialkylglycines into mice significantly attenuated thermal nociception as measured in the hot plate test. It is noteworthy that these compounds eliminated pain and neurogenic inflammation evoked by intradermal injection of capsaicin into the animal hindpaw, as well as the thermal hyperalgesia induced by tissue irritation with nitrogen mustard. In contrast, responses to mechanical stimuli were not modified by either compound. Modulation of sensory nerve fibers excitability appears to underlie the peptoid analgesic activity. Collectively, these results indicate that blockade of VR1 activity attenuates chemical and thermal nociception and hyperalgesia, supporting the tenet that this ionotropic receptor contributes to chemical and thermal sensitivity and pain perception in vivo. These trialkylglycine-based, noncompetitive VR1 antagonists may likely be developed into analgesics to treat inflammatory pain.
Beeley,
Can peptides be mimicked?
2000,
Pubmed Caterina,
A capsaicin-receptor homologue with a high threshold for noxious heat.
1999,
Pubmed
,
Xenbase Caterina,
Impaired nociception and pain sensation in mice lacking the capsaicin receptor.
2000,
Pubmed Caterina,
The vanilloid receptor: a molecular gateway to the pain pathway.
2001,
Pubmed Caterina,
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
1997,
Pubmed
,
Xenbase Davis,
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.
2000,
Pubmed Dray,
Ruthenium red blocks the capsaicin-induced increase in intracellular calcium and activation of membrane currents in sensory neurones as well as the activation of peripheral nociceptors in vitro.
1990,
Pubmed Ferrer-Montiel,
Engineering the NMDA receptor channel lining.
1999,
Pubmed Ferrer-Montiel,
Structural determinants of the blocker binding site in glutamate and NMDA receptor channels.
1998,
Pubmed
,
Xenbase Figliozzi,
Synthesis of N-substituted glycine peptoid libraries.
1996,
Pubmed García-Martínez,
Identification of an aspartic residue in the P-loop of the vanilloid receptor that modulates pore properties.
2000,
Pubmed
,
Xenbase Heppelmann,
Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat.
1997,
Pubmed Laird,
Role of central and peripheral tachykinin NK1 receptors in capsaicin-induced pain and hyperalgesia in mice.
2001,
Pubmed Lipinski,
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
2001,
Pubmed Melck,
Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
1999,
Pubmed
,
Xenbase Ostergaard,
Peptomers: a versatile approach for the preparation of diverse combinatorial peptidomimetic bead libraries.
1997,
Pubmed Pardridge,
Blood-brain barrier biology and methodology.
1999,
Pubmed Planells-Cases,
Arginine-rich peptides are blockers of VR-1 channels with analgesic activity.
2000,
Pubmed
,
Xenbase Premkumar,
Induction of vanilloid receptor channel activity by protein kinase C.
,
Pubmed
,
Xenbase Sterner,
Novel natural vanilloid receptor agonists: new therapeutic targets for drug development.
1999,
Pubmed Szallasi,
New perspectives on enigmatic vanilloid receptors.
2000,
Pubmed Szallasi,
Vanilloid (Capsaicin) receptors and mechanisms.
1999,
Pubmed Tominaga,
The cloned capsaicin receptor integrates multiple pain-producing stimuli.
1998,
Pubmed
,
Xenbase Viana,
Swelling-activated calcium signalling in cultured mouse primary sensory neurons.
2001,
Pubmed Williams,
Emerging molecular approaches to pain therapy.
1999,
Pubmed Wrigglesworth,
Analogues of capsaicin with agonist activity as novel analgesic agents: structure-activity studies. 4. Potent, orally active analgesics.
1996,
Pubmed Zygmunt,
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
1999,
Pubmed
,
Xenbase
